Svati Shah Named Associate Dean for Translational Research

The Duke University School of Medicine has announced that Svati H. Shah, MD, MS, MHS, has been named associate dean for translational research, effective immediately. Shah is the director of the Duke Center for Precision Health, a collaborative effort between the Duke Clinical and Translational Science Institute (CTSI) and the Precision Genomics Collaboratory that includes CTSI’s research site at Duke Kannapolis and the OneDukeGen initiative.

In her new role, Shah will serve in an expanded capacity from her previous role as associate dean of genomics. She will provide strategic vision, development, and oversight of translational research initiatives within the School of Medicine. Specifically, she will be responsible for overseeing biobanking service centers and the integration of large biologic datasets including storage and computer environments. Her leadership portfolio will also include the OneDukeBio Integrated Biospecimen Network. She will work in close collaboration with associate and vice deans in related disciplines to ensure program alignment across the School of Medicine.

Shah has been a member of the Department of Medicine faculty since 2005. In addition to her leadership at CTSI, she is also Ursula Geller Distinguished Professor of Research in Cardiovascular Disease, professor of bioinformatics and biostatistics, director of the Duke School of Medicine Precision Genomics Collaboratory, director of the Adult Cardiovascular Genetics Clinic, and a member of the Duke Molecular Physiology Institute and Duke Clinical Research Institute. As founding director of the Duke Center for Precision Health, chair of the research committee for the Board of Directors of the American Health Association and member of the Board of Directors of the Sarnoff Foundation, Shah’s talent as a leader has been demonstrated both inside and outside the School of Medicine.

Shah is a physician scientist and practicing cardiologist who sees patients and families with cardiovascular genetic disorders. Upon completing her internal medicine residency at the Brigham and Women’s Hospital, she came to Duke for a cardiology fellowship in 2001, where she also completed a master’s degree in medical genomics and a postdoctoral fellowship in genetic epidemiology. 

The announcement was made Jan. 9 by Mary E. Klotman, MD, executive vice president for Health Affairs and dean of the Duke University School of Medicine; Susanna Naggie, MD, MHS, vice dean for Clinical and Translational Research and director of Duke CTSI; and Colin S. Duckett, PhD, vice dean for Basic Science.